The concept of transferring genes to tissues for clinical applications has been discussed for nearly half a century, but the ability to manipulate genetic material via recombinant DNA technology has brought this goal to reality. ‘Gene Therapy’ covers both the research and clinical applications of the new genetic therapy techniques currently being developed. The application of molecular biology has revolutionized researchers understanding of many diseases and has been readily applied for diagnostic purposes. Now-a-day this is originally conceived as a way to treat life-threatening disorders (inborn errors, cancers) refractory to conventional treatment, gene therapy now is considered for many non–life-threatening conditions, including those adversely affecting a patient’s quality of life. The lack of suitable treatment has become a rational basis for extending the scope of gene therapy. It is not very far, the justifiable optimism that with increased biotechnological improvement, gene therapy will become a standard part of clinical practice.
The concept of transferring genes to tissues for clinical applications has been discussed for nearly half a century, but the ability to manipulate genetic material via recombinant DNA technology has brought this goal to reality. ‘Gene Therapy’ covers both the research and clinical applications of the new genetic therapy techniques currently being developed. The application of molecular biology has revolutionized researchers understanding of many diseases and has been readily applied for diagnostic purposes. Now-a-day this is originally conceived as a way to treat life-threatening disorders (inborn errors, cancers) refractory to conventional treatment, gene therapy now is considered for many non–life-threatening conditions, including those adversely affecting a patient’s quality of life. The lack of suitable treatment has become a rational basis for extending the scope of gene therapy. It is not very far, the justifiable optimism that with increased biotechnological improvement, gene therapy will become a standard part of clinical practice.
A good comprehensive review of gene delivery and gene therapy. especially for master of pharmacy 2nd-semester students as per the PCI syllabus of subject Molecular pharmaceutics.
List of contents under this ppt :
{A} GENE THERAPY
(1) Definition
(2) Introduction
(3) History
(4) Ex-Vivo gene therapy
(5) In-Vivo gene therapy
(6) Germline gene therapy
(7) Advantages of gene therapy
(8) Disadvantages of gene therapy
(9) Potential target diseases for gene therapy
a. inherited disorders :- ADA SCID, Chronic granulomatous, Hemophelia
b. Cancer
{B} GENE DELIVERY
(1) Definition
(2) Introduction
(3) Types of vectors
a. Viral :- Retrovirus, Adenovirus, Adeno associated virus, Herps simplex virus
b. Non viral :-
Physical methods - Gene gun, Microinjection, Electroporation, Sonoporation
Chemical methods - Oligonucleotides, Lipoplexes, Polyplexes, Dendrimers, Nanoparticles.
Chromosomes in most of the bacteria are single circular DNA molecule which are Haploid
Exceptions include:
Bacteria with linear chromosomes
Bacteria with more than one chromosome
A good comprehensive review of gene delivery and gene therapy. especially for master of pharmacy 2nd-semester students as per the PCI syllabus of subject Molecular pharmaceutics.
List of contents under this ppt :
{A} GENE THERAPY
(1) Definition
(2) Introduction
(3) History
(4) Ex-Vivo gene therapy
(5) In-Vivo gene therapy
(6) Germline gene therapy
(7) Advantages of gene therapy
(8) Disadvantages of gene therapy
(9) Potential target diseases for gene therapy
a. inherited disorders :- ADA SCID, Chronic granulomatous, Hemophelia
b. Cancer
{B} GENE DELIVERY
(1) Definition
(2) Introduction
(3) Types of vectors
a. Viral :- Retrovirus, Adenovirus, Adeno associated virus, Herps simplex virus
b. Non viral :-
Physical methods - Gene gun, Microinjection, Electroporation, Sonoporation
Chemical methods - Oligonucleotides, Lipoplexes, Polyplexes, Dendrimers, Nanoparticles.
Chromosomes in most of the bacteria are single circular DNA molecule which are Haploid
Exceptions include:
Bacteria with linear chromosomes
Bacteria with more than one chromosome
DNA is a long polymer of simple units called nucleotides. Each one contains a phosphate group (acid component), a sugar group (neutral component) and a nitrogen base (basic component).
I will show some news that are important to the understanding of the importance of the genetic transcription and how it provides important tools to the actual medicine
Describe in your own words the benefits, but also the problems of ha.pdfarenamobiles123
Describe in your own words the benefits, but also the problems of having the human genome
deciphered. Write several paragraphs.
Solution
The history of the human race has been filled with curiosity and discovery about our abilities and
limitations. As an egotistical creature with a seemingly unstoppable desire for new
accomplishments, we attempt feats with emotion and tenacity. People worldwide raced to be the
first to discover the secrets and the ability of flight. Enormous amounts of monies were spent on
sending people into space and the race to land on the moon. With the rapid growth of scientific
knowledge and experimental methods, humans have begun to unravel and challenge another
mystery, the discovery of the entire genetic make-up of the human body.
This endeavor, the Human Genome Project (HGP), has created hopes and expectations about
better health care. It has also brought forth serious social issues. To understand the potential
positive and negative issues, we must first understand the history and technical aspects of the
HGP.
History of the Human Genome Project
The HGP has an ultimate goal of identifying and locating the positions of all genes in the human
body. A researcher named Renato Dulbecco first suggested the idea of such a project while the
U.S. Department of Energy (DOE) was also considering the same project because issues related
to radiation and chemical exposure were being raised. Military and civilian populations were
being exposed to radiation and possible carcinogenic chemicals through atomic testing, the use
of Agent Orange in Vietnam, and possible nuclear power facility accidents. Genetic knowledge
was needed to determine the resiliency of the human genome.
Worldwide discussion about a HGP began in 1985. In 1986, the DOE announced its\' Human
Genome Initiative which emphasized the development of resources and technologies for genome
mapping, sequencing, computation, and infrastructure support that would lead to the entire
human genome map. United States involvement began in October 1990 and was coordinated by
the DOE and the National Institute of Health (NIH). With an estimated cost of 3 billion dollars,
sources of funding also include the National Science Foundation (NSF) and the Howard Hughes
Medical Institute (HHMI). Because of the involvement of the NIH, DOE, and NSF who receive
U.S. Congressional funding, the HGP is partly funded through federal tax dollars. Expected to
last 15 years, technological advancements have accelerated the expected date of completion to
the year 2003. This completion date would coincide with the 50th anniversary of Watson and
Crick\'s description of the structure of DNA molecule.
Human Genome Project Goals
The specific goals of the HGP are to::
Technical Aspects of the HGP
Mapping Strategies
To sequence the human genome, maps are needed. Physical maps are a series of overlapping
pieces of DNA isolated in bacteria. Physical maps are used to describe the DNA\'s chemical
characteristics..
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
“Clever” DNA may help bacteria survive and How DNA is “edited” to correct genetic diseases
1. “Clever” DNA may help bacteria
survive and How DNA is “edited” to
correct genetic diseases.
Carolina Carvajal Miranda
Medicine Student
Universidad Pontificia Bolivariana
Medellín
2. FOLDING
Molecular biology
Medical student
3° Semester
Teacher
Lina Maria Martinez. S
July 28, 2014
Medellin, Colombia
Bibliography
Medical Utility
With the knolege and the
investigation studies of the
DNA structure, scientists can
now aproach certain
mecanisms in a large form.
The change in DNA structure
can now be the key
phenomenon that will allow us
to understand how certain
bacterias can become active
when transfered from a specific
enviroment to the human
body, and even, in some cases,
become more eficient in their
reproduction and survival
mecanisms.
Also, the discovery of specific
funtions of some enzyms that
can edit and restore genes can
take us closer to cure and treat
genetic diseases and gene
mutation alterations in order to
help patients with severe
medical conditions.
Carolina Carvajal Miranda
DNA Estructure
•Mark D. Szczelkuna, Maria S.
Tikhomirovab, Tomas Sinkunasd, Giedrius
Gasiunasd, Tautvydas Karvelisd, Patrizia
Pscherac, Virginijus Siksnysd and Ralf
Seidel. Direct observation of R-loop
formation by single RNA-guided Cas9
and Cascade effector complexes. PNAS,
May 2014
•Monash University. "'Clever' DNA may help
bacteria survive." ScienceDaily.
ScienceDaily, 4 June 2014.
<www.sciencedaily.com/releases/2014/06/1
40604105536.htm>.
3. FOLDING
How DNA is 'edited' to
correct genetic diseases
An international team of scientists at the
Universities of Bristol, Münster and the
Lithuanian Institute of Biotechnology
observed the mecanisms by which a type
of enzymes called CRISPR bind and alter
the structure of DNA. This discovery can
now help to identify how this genome
editing tools work and how they can be
used to correct genetic diseases in
humans. These enzymes are believed to
target a single combination of letters within
the three billion base pairs of the DNA
molecule. The targeting process requires
the CRISPR enzyme to pull apart the DNA
strands and insert in them a similar RNA
to form a sequence-specific structure
called an 'R-loop'.
This single molecule assays can helped
understand the influence of DNA
sequences on R-loop formation. “In the
future this may help in the rational re-
engineering of CRISPR enzymes to
increase their accuracy and minimise off-
target effects. This will be vital if we are to
ultimately apply these tools to correct
genetic diseases in patients."
'Clever' DNA may help
bacteria survive
A recent research study, published in the
journal Proceedings of the Royal Society
Interface, has shown that bacterial DNA
can change from the regular double helix
B form , to the more compact A-DNA
form, using a specialized process called
the B-A-B transition. This process takes
pleace when bacteria is faced with
adverse conditions, and doesn’t affect its
capacity to function normally and
reproduce.
Even though there is no biological reason
why this mecnism also happends in the
human body cells, its recurrence in
bacteria results very interesting.The
interdisciplinary team at Monash
investigated four species of bacteria.
They used a carefull process of hydrating
and then, dehydrating the cells and
studied the results with a infrared based
tecnique that detects DNA vibrations. It
was found that all species studied
underwent the BAB transition.
With the first phase complete, now
investigations teams can center their
attention on working with other
conditions such as temperature, pH
levels, oxygen, nutrients and
antimicrobials and discover if DNA
structur changes occur as well.
Introduction
The DNA has the vital job in
carrying the genetic code
which defines all living
organisms. The complex role of
the DNA gives us a crucial
target
point that
can be mo-
dified and
edited to
obtain cer-
tain caracte-
ristics. The discovery of
bacteria that can reshape their
DNA to survive dehydration
and other extreme conditions,
or the capacity of certain
enzymes to edit specific
secuences of DNA, gives us a
solid base to secure the fact
that variability in DNA can
complitly change the course of
the human body responce
mecanisms.
I think this discovery brings us a step
foward in the understanding of how
enzymes can edit and modify specific
secuences of DNA, bringing us closer in
treating genetic deseases.
In my opinion, this research can now explain how
certain microorganisms can develop extreme
resistance to adverce conditions, and later on, help
us develop a more specialized form of treatment to
attack infectant bacteria that survive using this type
mecanisms.
OBSERVATION
OBSERVATION
4. INTRODUCTION
• Bacteria can reshape
their DNA to survive
dehydration.
•Understanding how enzymes “edit”
genes, paving the way for correcting
genetic diseases in patients.
5. “Clever” DNA may help
bacteria survive(ScienceDaily, 4 June 2014 )
Bacterial DNA can change from B-DNA (double helix) , to the more
compact A-DNA form, when exposed to adverse conditions such as
dehydration.
6. “Clever” DNA may help bacteria
survive(ScienceDaily, 4 June 2014 )
B-A-B transition allows
structure change in response to
environmental variation.
No impact on the ability to
function and reproduce.
Unique structural alteration that
generates the B-DNA change to
A-DNA, and then revert back to
its original B-DNA form.
7. "Our findings may be important in understanding
how dormant bacteria that are transferred from dry
surfaces may become active and reproduce in the
human body,” Associate Professor Wood said.
“Clever” DNA may help bacteria
survive(ScienceDaily, 4 June 2014 )
8. “Clever” DNA may help bacteria
survive(ScienceDaily, 4 June 2014 )
B FORM
Bacteria can survive by adopting the A-DNA form after
the majority of water is removed.
A FORM
Dyhadration
9. “Clever” DNA may help bacteria
survive(ScienceDaily, 4 June 2014 )
Infrared based tecnique detects DNA vibrations.
10. OBSERVATION
In my opinion, this research can now explain how
certain microorganisms can develop extreme
resistance to adverse conditions, and later on,
help us develop a more specialized form of
treatment to attack infectant bacteria that survive
using this type of mecanisms.
11. How DNA is “edited” to
correct genetic diseases
Enzymes “edit” genes
paving the way for
correcting genetic
diseases in patients.
CRISPR enzymes
(Cas9) can be used to
edit the human
genome.
(ScienceDaily, 26 May 2014)
12.
13. The targeting
process requires the
CRISPR enzymes
to pull apart the
DNA strands and
then insert the RNA
to produce a specific
sequence structure
called an 'R-loop'.
How DNA is 'edited' to correct
genetic diseasesScienceDaily, 26 May 2014)
14. How DNA is 'edited' to correct
genetic diseases
DNA sequence influences
R-loop formation.
Re-engineering of CRISPR
enzymes to increase
accuracy and minimize off-
target effects.
ScienceDaily, 26 May 2014)
Correct genetic diseases in
patients.
15. OBSERVATION
I think this discovery brings us a step foward in
the understanding of how enzymes can edit and
modify specific secuences of DNA, bringing us
closer in treating genetic diseases .
17. MEDICAL UTILITY
“Clever” DNA may help bacteria survive
•The discovery of the changes in DNA
structure under extreme circumstances is
a key point in the future development of
specific treatments for bacterial infections
that are dificult to deal with.
•It may also help us understand specific
mecanisms that microorganisms use and
identify key factors in their survival.
18. • Lastly, if biological proof of this mecanisms can be found in the human
body cells it may be a whole new starting point for scientists in the
treatment of diseases that put cells under temperature, pH levels,
oxygen, nutrients and antimicrobial stress.
MEDICAL UTILITY
“Clever” DNA may help bacteria survive
19. MEDICAL UTILITY
How DNA is “edited” to correct genetic diseases
•In the future, these studies can be used to
engineer enzymes alterating their target
points in the human DNA. This will be a
vital step in correcting genetic diseases in
patients.
20. BIBLIOGRAPHY
MARTINEZ S., Lina Maria. Biologia molecular. 5. ed. Medellin: UPB.
Fac. de Medicina,
2009.265 p.
Monash University. "'Clever' DNA may help bacteria survive."
ScienceDaily. ScienceDaily, 4 June 2014.
<www.sciencedaily.com/releases/2014/06/140604105536.htm>.
Mark D. Szczelkuna, Maria S. Tikhomirovab, Tomas Sinkunasd,
Giedrius Gasiunasd, Tautvydas Karvelisd, Patrizia Pscherac,
Virginijus Siksnysd and Ralf Seidel. Direct observation of R-loop
formation by single RNA-guided Cas9 and Cascade effector
complexes. PNAS, May 2014